Barclays Increases Ortho Clinical Diagnostics’ Revolver to $500MM
Subsidiaries of Ortho Clinical Diagnostics increased the revolving credit facility under a 2014 credit agreement by $150 million to $500 million. According to an 8K, Barclays Bank is serving as administrative agent and collateral agent for the facility.
February 10, 2021
Barclays Bank | Ortho-Clinical Diagnostics
Phil Neuffer